Cite
HARVARD Citation
Rech, J. et al. (n.d.). FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study. Annals of the rheumatic diseases. pp. 516-517. [Online].